Lactate drives CD38 signaling to promote Epithelial‐Mesenchymal Transition through Snail induction in non‐small cell lung cancer cells

Author:

Lu Yating12,Yang Yang12,Chang Tao12,Jiang Qiyun13,Yang Chenfeng145,Fu Chunzhe16,Wei Huijun17,He Yuanpeng127,Wu Zhihao12789

Affiliation:

1. Research Laboratory of Tumor Microenvironment Wannan Medical College Wuhu China

2. School of Clinical Medicine Wannan Medical College Wuhu China

3. School of Public Health Wannan Medical College Wuhu China

4. School of Pharmacy Wannan Medical College Wuhu China

5. Provincial Engineering Laboratory for Screening and Re‐evaluation of Active Compounds of Herbal Medicines in Southern Anhui Wannan Medical College Wuhu China

6. School of Anesthesiology Wannan Medical College Wuhu China

7. Anhui Province Key Laboratory of Active Biological Macro‐molecules Research Wannan Medical College Wuhu China

8. Key Laboratory of Non‐coding RNA Transformation Research of Anhui Higher Education Institution Wannan Medical College Wuhu China

9. Anhui Provincial Engineering Research Center for Dental Materials and Application Wannan Medical College Wuhu China

Abstract

AbstractCD38 is the main NADase in mammalian cells. It regulates the homeostasis of nicotinamide adenine dinucleotide (NAD+) and extracellular nucleotides. Its function plays an important role in infection and aging. However, its potential functions in tumor cells have not been fully elucidated. In the present study, we demonstrated that lactate, which is derived from tumor metabolism remodeling, upregulates the expression of CD38 through OXPHOS‐driven Hippo‐TAZ pathway. The highly expressed CD38 converts NAD + to adenosine through the CD203a/CD73 complex and adenosine binds and activates its receptor A2AR, inducing the expression of Snail and promoting the invasion and metastasis of lung cancer cells. This finding elucidates a new perspective on the interplay between NAD + metabolism and glycolysis in tumor development.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3